Xenon Pharmaceuticals Inc (XENE)
39.83
-1.92
(-4.60%)
USD |
NASDAQ |
Nov 15, 16:00
39.84
+0.01
(+0.03%)
After-Hours: 20:00
Xenon Pharmaceuticals Free Cash Flow (Quarterly): -34.19M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -34.19M |
March 31, 2024 | -43.37M |
December 31, 2023 | -35.54M |
September 30, 2023 | -43.43M |
June 30, 2023 | -35.35M |
March 31, 2023 | -36.62M |
December 31, 2022 | -34.48M |
September 30, 2022 | -30.79M |
June 30, 2022 | -17.41M |
March 31, 2022 | -18.64M |
December 31, 2021 | -21.22M |
September 30, 2021 | -15.23M |
June 30, 2021 | -13.99M |
March 31, 2021 | -21.11M |
December 31, 2020 | -13.94M |
September 30, 2020 | -11.95M |
June 30, 2020 | -11.16M |
March 31, 2020 | -13.71M |
December 31, 2019 | 19.19M |
September 30, 2019 | -7.103M |
June 30, 2019 | -9.012M |
Date | Value |
---|---|
March 31, 2019 | -9.031M |
December 31, 2018 | -7.412M |
September 30, 2018 | -13.74M |
June 30, 2018 | -5.675M |
March 31, 2018 | -8.40M |
December 31, 2017 | -6.901M |
September 30, 2017 | -8.64M |
June 30, 2017 | -6.903M |
March 31, 2017 | -6.597M |
December 31, 2016 | -4.698M |
September 30, 2016 | -4.57M |
June 30, 2016 | -5.551M |
March 31, 2016 | -5.027M |
December 31, 2015 | -5.39M |
September 30, 2015 | -5.103M |
June 30, 2015 | -2.53M |
March 31, 2015 | -5.631M |
December 31, 2014 | -3.727M |
September 30, 2014 | 6.028M |
June 30, 2014 | -2.242M |
March 31, 2014 | -1.322M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-43.43M
Minimum
Sep 2023
19.19M
Maximum
Dec 2019
-22.79M
Average
-21.11M
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 16.90M |
Edesa Biotech Inc | -0.8565M |
Lexaria Bioscience Corp | -1.288M |
ESSA Pharma Inc | -5.745M |
ImmunoPrecise Antibodies Ltd | -1.524M |